Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Healthcare Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Theratechnologies Inc > Paul's Amazing Leadership
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by canadapieton Jul 12, 2023 11:14am
143 Views
Post# 35537423

RE:RE:RE:Paul's Amazing Leadership

RE:RE:RE:Paul's Amazing Leadership
Holysh..........., 

well it was written all over here for a long time!!! 
They, the BOD, are there for only one reason, their paycheque!!
Look at the chart for over 5 years and you know they did a horrible job.
And they were and are liars because for how many years now are the saying they
are in negotiations with potential partners???? Telling everybody how ridiculous low the share price is??? 
"Once upon a time"......this was a promising company......
The last one may turn out the lights......, rip TH!! 




Bucknelly21 - (7/12/2023 10:52:21 AM)
RE:RE:Paul's Amazing Leadership
My opinion is they are just throwing dart and hope one sticks... I hey have no real conviction for what they are and who they are hence no one there ever buys shares. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities